Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Clinical trial NCT00079768 · COMPLETED
Trial details
- NCT number
- NCT00079768
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.